13D/13G Filings - Syntone Ventures LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-04-17
9:38 pm
Purchase
2024-04-15 13D Outlook Therapeutics, Inc.
OTLK
Syntone Ventures LLC 2,776,867
11.400%
2,776,867increase
(New Position)
Filing
History
2021-02-04
8:55 pm
Purchase
2021-02-03 13D Outlook Therapeutics, Inc.
OTLK
Syntone Ventures LLC 991,152
11.700%
191,152increase
(+23.89%)
Filing
History
2020-06-12
4:17 pm
Purchase
2020-06-02 13D Outlook Therapeutics, Inc.
OTLK
Syntone Ventures LLC 800,000
14.900%
800,000increase
(New Position)
Filing
History